3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Nasopharyngeal Carcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Melanoma
2
Carcinoma, Non-Small-Cell Lung
2
Recurrence
1
Oligoprogressive
1
Neoplasms
1
Neoplasm Metastasis
1
NSCLC
1
Meningeal Carcinomatosis
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Advanced Solid Tumors
1
Interventions
cabozantinib
2
Surveys and Questionnaires
2
Ipilimumab
2
Axitinib
2
zimberelimab
1
temsirolimus
1
salicylhydroxamic acid
1
orellanine
1
brodalumab
1
belzutifan
1
atezolizumab
1
Selenomethionine
1
Ropivacaine
1
Radionuclide Imaging
1
Pluvicto
1
Patient Reported Outcome Measures
1
Methods
1
Magnetic Resonance Imaging
1
Health Promotion
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Genetic Counseling
1
Everolimus
1
Erlotinib Hydrochloride
1
Educational Status
1
Early Intervention, Educational
1
Docetaxel
1
Dacarbazine
1
Counseling
1
Blood Component Removal
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Kidney Neoplasms
×
Immune Checkpoint Inhibitors
×
30 days
×
Clear all
No trials found.